Grunenthal Competitors and Similar CompaniesClear all

Grunenthal's competitors and similar companies include Zentiva, Guizhou Sanli Pharmaceutical, Aepodia and Remington Davis.

	Grunenthal Grunenthal is a pharmaceutical company.	Zentiva Zentiva is a company that develops and manufactures generic medicines.	Guizhou Sanli Pharmaceutical Guizhou Sanli Pharmaceutical (贵州三力制药股份有限公) researches and develops medicinal products.	Aepodia Aepodia is a company specialized in the strategy and delivery of drugs and the development of medical devices.	Remington Davis Remington Davis is a research institute offering clinical research, and patient care services.
Founding Date	Founding Date 1946	Founding Date 2003	Founding Date 1995	Founding Date 2007	Founding Date 1992
Type	Type Private	Type Private	Type Public	Type Private	Type Private
Tags	Tags Healthcare clinical research drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare clinical research drug development pharma	Tags Healthcare clinical research drug development pharma	Tags Healthcare clinical research drug development pharma
Locations	Locations Aachen, DE HQ Brunn Am Gebirge, AT Zaventem, BE Santiago, CL Apartadó, CO København, DK see more	Locations CZ HQ Tallinn, EE Paris, FR Mumbai, IN Milano, IT Milano, IT Rīga, LV see more	Locations An Shun Shi, CN HQ	Locations Ottignies-Louvain-la-Neuve, BE HQ Villebon Sur Yvette, FR	Locations Columbus, US HQ
Employees	Employees 4,590	Employees 3,4721% increase	Employees 2,85225% increase	Employees 6	Employees 21
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) Kč2.3b (FY, 2021)	Revenue (est.) ¥2.1b (FY, 2024)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods Kč807.2m (FY, 2021)	Cost of goods ¥650m (FY, 2024)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit Kč1.5b (FY, 2021)	Gross profit ¥1.5b (FY, 2024)	Gross profit N/A	Gross profit N/A
Net income	Net income N/A	Net income (Kč831.2m) (FY, 2021)	Net income ¥279.8m (FY, 2024)	Net income N/A	Net income N/A